Randomized Phase II/III Trial Comparing Hepatectomy, Followed by mFOLFOX6 With Hepatectomy Alone for Liver Metastasis From Colorectal Cancer: Long-Term Results of JCOG0603
Journal of Clinical Oncology · 20.05.2026 · 44 (15) · 1395-1400
DOI: 10.1200/jco-25-01231 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.05.2026. Verfasst von Yukihide Kanemitsu und 20 weiteren Autor:innen. Beteiligte Einrichtung: National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Liver Neoplasms, Hepatectomy, Colorectal Neoplasms, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
JCOG0603 demonstrated improved disease-free survival (DFS) with adjuvant mFOLFOX6 after hepatectomy compared with hepatectomy alone in colorectal liver-only metastasis (CRLM), but the overall survival (OS) data were immature. Here, we report OS after long-term follow-up. Eligible patients with colorectal adenocarcinoma and an unlimited number of liver metastases were randomized to adjuvant mFOLFOX6 or hepatectomy alone. DFS was the primary endpoint, and OS was a secondary endpoint. Between March 2007 and January 2019, 151 and 149 patients were randomized to adjuvant chemotherapy and hepatectomy alone, respectively. At a median follow-up of 7.7 years for disease-free surviving patients, 54 (35.8%) and 51 (34.2%) patients had died in the respective arms, (hazard ratio [HR], 1.07 [95% CI, 0.73 to 1.57]). Five-year OS was 73.4% (95% CI, 65.5 to 79.7) and 80.1% (95% CI, 72.6 to 85.7) and 7-year OS was 69.4% (95% CI, 61.2 to 76.2) and 72.4% (95% CI, 64.2 to 79.1), respectively. One patient in the adjuvant chemotherapy arm possibly died of protocol treatment-related toxicity, and one in the hepatectomy-alone arm died of post-protocol treatment complications. Five-year DFS was respectively 49.7% (95% CI, 41.5 to 57.3) and 40.5% (95% CI, 32.5 to 48.3) in the adjuvant chemotherapy and hepatectomy-alone arms (HR, 0.72 [95% CI, 0.54 to 0.97]). Long-term OS did not differ with adjuvant mFOLFOX6 compared with hepatectomy alone in resectable CRLM. Adjuvant mFOLFOX6 may delay recurrence but did not improve long-term survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Cancer Center Hospital, Tokyo, Japan.
- Aichi Cancer Center Hospital, Nagoya, Japan.
- Osaka International Cancer Institute, Osaka, Japan.
- Shizuoka Cancer Center Hospital, Shizuoka, Japan.
- Kanagawa Cancer Center, Kanagawa, Japan.
- Yokohama City University Medical Center, Yokohama, Japan.
ORCID-Profile: Yukihide Kanemitsu, Yasuhiro Shimizu, Junki Mizusawa, Yoshitaka Inaba, Shunsuke Tsukamoto, Atsuo Takashima, Yusuke Suwa, Yusuke Kinugasa, Yasumasa Takii, Hiroyuki Bando, Takaya Kobatake, Masafumi Inomata, Hiroshi Katayama
Zitieren
APA
Kanemitsu, Y., Shimizu, Y., Mizusawa, J., Inaba, Y., Tsukamoto, S., Takashima, A., Ohue, M., Komori, K., Shiomi, A., Shiozawa, M., Suwa, Y., Suto, T., Kinugasa, Y., Takii, Y., Bando, H., Kobatake, T., Inomata, M., Shimada, Y., Katayama, H., …, & JCOG Colorectal Cancer Study Group (2026). Randomized Phase II/III Trial Comparing Hepatectomy, Followed by mFOLFOX6 With Hepatectomy Alone for Liver Metastasis From Colorectal Cancer: Long-Term Results of JCOG0603. Journal of Clinical Oncology, 44(15), 1395-1400. https://doi.org/10.1200/jco-25-01231
Vancouver
Kanemitsu Y, Shimizu Y, Mizusawa J, Inaba Y, Tsukamoto S, Takashima A, et al. Randomized Phase II/III Trial Comparing Hepatectomy, Followed by mFOLFOX6 With Hepatectomy Alone for Liver Metastasis From Colorectal Cancer: Long-Term Results of JCOG0603. Journal of Clinical Oncology. 2026;44(15):1395-1400. doi:10.1200/jco-25-01231
BibTeX
@article{Kanemitsu2026,
author = {Kanemitsu, Yukihide and Shimizu, Yasuhiro and Mizusawa, Junki and Inaba, Yoshitaka and Tsukamoto, Shunsuke and Takashima, Atsuo and Ohue, Masayuki and Komori, Koji and Shiomi, Akio and Shiozawa, Manabu and Suwa, Yusuke and Suto, Takeshi and Kinugasa, Yusuke and Takii, Yasumasa and Bando, Hiroyuki and Kobatake, Takaya and Inomata, Masafumi and Shimada, Yasuhiro and Katayama, Hiroshi and Fukuda, Haruhiko and JCOG Colorectal Cancer Study Group, JCOG Colorectal Cancer Study Group},
title = {Randomized Phase II/III Trial Comparing Hepatectomy, Followed by mFOLFOX6 With Hepatectomy Alone for Liver Metastasis From Colorectal Cancer: Long-Term Results of JCOG0603},
journal = {Journal of Clinical Oncology},
year = {2026},
volume = {44},
number = {15},
pages = {1395--1400},
doi = {10.1200/jco-25-01231}
}
EUVIMED